Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Denise Toscani, Benedetta Dalla Palma, MD, Carla Palumbo, Marzia Ferretti, Marina Bolzoni, Daniela Guasco, Cristina Mancini, MD, Eugenia Martella, MD, Mirca Lazzaretti, PhD, Mario Pedrazzoni, MD, PhD, Franco Aversa, MD, Nicola Giuliani

Blood (2012) 120 (21): 3978.

https://doi.org/10.1182/blood.V120.21.3978.3978

Published: 2012

Journal Articles

Hypoxia-Inducible Factor (HIF)-1a Is A Therapeutic Target in Myeloma-Induced Angiogenesis and Bone Destruction in Vivo .

Marina Bolzoni, Paola Storti, PhD, Gaetano Donofrio, PhD, Irma Airoldi, PhD, Daniela Guasco, Denise Toscani, Marco Peronaci, Eugenia Martella, MD, Mirca Lazzaretti, PhD, Luca Agnelli, PhD, Ken Patrene, Cristina Mancini, MD, Martine Amiot, PhD, Antonino Neri, Simona Colla, Judith Anderson, Franco Aversa, MD, G. David Roodman, MD, PhD, Nicola Giuliani

Blood (2012) 120 (21): 2947.

https://doi.org/10.1182/blood.V120.21.2947.2947

Published: 2012

Journal Articles

Hypoxia-Inducible Factor (HIF)-1α Is a Therapeutic Target in Myeloma-Induced Angiogenesis

Paola Storti, PhD, Irma Airoldi, PhD, Marina Bolzoni, Mirca Lazzaretti, PhD, Daniela Guasco, Luca Agnelli, PhD, Eugenia Martella, MD, Cristina Mancini, MD, Antonino Neri, MD, Gaetano Donofrio, PhD, Nicola Giuliani, M.D., Ph.D.

Blood (2011) 118 (21): 3927.

https://doi.org/10.1182/blood.V118.21.3927.3927

Published: 2011

Journal Articles

The Activation of Wnt5a-Mediated Non Canonical Wnt Signaling in Human Bone Marrow Osteoprogenitor Cells Increases Osteoblastogenesis and Counterbalances the Inhibitory Effect of Myeloma Cells on Ror2/FZD5 Expression,

Marina Bolzoni, Paola Storti, PhD, Daniela Guasco, Mirca Lazzaretti, PhD, Eugenia Martella, MD, Cristina Mancini, MD, Luca Agnelli, PhD, Sabrina Bonomini, Antonino Neri, MD, Gaetano Donofrio, PhD, Nicola Giuliani, M.D., Ph.D.

Blood (2011) 118 (21): 3928.

https://doi.org/10.1182/blood.V118.21.3928.3928

Published: 2011

Journal Articles

In Vitro and In Vivo Evidences of Osteocyte Involvement In Myeloma-Induced Osteolysis

Nicola Giuliani, MD, PhD, Paola Storti, PhD, Manuela Abeltino, Marina Bolzoni, Marzia Ferretti, Mirca Lazzaretti, PhD, Benedetta Dalla Palma, Katia Todoerti, PhD, Eugenia Martella, MD, Luca Agnelli, Antonino Neri, MD, Vittorio Rizzoli, MD, PhD, Carla Palumbo

Blood (2010) 116 (21): 131.

https://doi.org/10.1182/blood.V116.21.131.131

Published: 2010

Journal Articles

Macrophage Inflammatory Protein (MIP)-3α/CCL20 and Its Receptor CCR6 Are Overexpressed in the Bone Microenvironment and Involved in Osteoclast Formation in Multiple Myeloma Patients.

Nicola Giuliani, MD, PhD, Gina Lisignoli, PhD, Sara Tagliaferri, Mirca Lazzaretti, PhD, Francesca Morandi, Simona Colla, PhD, Cristina Manferdini, Beatrice Tonnarelli, Vittorio Rizzoli, MD, PhD

Blood (2007) 110 (11): 3510.

https://doi.org/10.1182/blood.V110.11.3510.3510

Published: 2007

Journal Articles

The Proteasome Inhibitor Bortezomib Affects Osteoblastogenesis and Bone Formation In Vitro and In Vivo in Multiple Myeloma Patients.

Nicola Giuliani, MD, PhD, Francesca Morandi, Sara Tagliaferri, Mirca Lazzaretti, PHD, Sabrina Bonomini, Monica Crugnola, MD, Daniela Petrò, MD, Cristina Mancini, MD, Eugenia Martella, MD, Vittorio Rizzoli, MD, PHD

Blood (2006) 108 (11): 508.

https://doi.org/10.1182/blood.V108.11.508.508

Published: 2006

Journal Articles

Immunohistologic Identification and Quantification of Human Bone Marrow Hematopoietic Stem Cells.

Federico Quaini, MD, Mirca Lazzaretti, PhD, Lorena Carranza, PhD, Francesca Ferraro, MD, Sabrina Bonomini, PhD, Konrad Urbanek, MD, Cristina Mancini, MD, Nicola Giuliani, MD, Piero Anversa, MD, Vittorio Rizzoli, MD

Blood (2005) 106 (11): 2301.

https://doi.org/10.1182/blood.V106.11.2301.2301

Published: 2005

NARROW

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Hypoxia-Inducible Factor (HIF)-1a Is A Therapeutic Target in Myeloma-Induced Angiogenesis and Bone Destruction in Vivo .

Hypoxia-Inducible Factor (HIF)-1α Is a Therapeutic Target in Myeloma-Induced Angiogenesis

The Activation of Wnt5a-Mediated Non Canonical Wnt Signaling in Human Bone Marrow Osteoprogenitor Cells Increases Osteoblastogenesis and Counterbalances the Inhibitory Effect of Myeloma Cells on Ror2/FZD5 Expression,

In Vitro and In Vivo Evidences of Osteocyte Involvement In Myeloma-Induced Osteolysis

Macrophage Inflammatory Protein (MIP)-3α/CCL20 and Its Receptor CCR6 Are Overexpressed in the Bone Microenvironment and Involved in Osteoclast Formation in Multiple Myeloma Patients.

The Proteasome Inhibitor Bortezomib Affects Osteoblastogenesis and Bone Formation In Vitro and In Vivo in Multiple Myeloma Patients.

Immunohistologic Identification and Quantification of Human Bone Marrow Hematopoietic Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only